Fagron Compounding Services: Norepinephrine Bitartrate,16mg Per

Recall Summary Fagron Compounding Services is recalling norepinephrine Bitartrate 16mg per 250mL injection vials distributed nationwide because the sterility of the product cannot be assured and a blue plastic piece on the administration port may detach during use. The recall affects vials with NDC 71266-5026-02 that were distributed across all U.S. states and Washington, D.C. This is a Class II recall, meaning use of the product could cause serious health problems.

Recalling firm

Fagron Compounding Services

Product

norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02

Reason

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-03-20

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

Nationwide in the U.S.A.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/1c134b40-49ed-4800-93ae-22ee301a7745